1. Home
  2. WHD vs IOVA Comparison

WHD vs IOVA Comparison

Compare WHD & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WHD
  • IOVA
  • Stock Information
  • Founded
  • WHD 2011
  • IOVA 2007
  • Country
  • WHD United States
  • IOVA United States
  • Employees
  • WHD N/A
  • IOVA N/A
  • Industry
  • WHD Metal Fabrications
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WHD Industrials
  • IOVA Health Care
  • Exchange
  • WHD Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • WHD 2.9B
  • IOVA 975.1M
  • IPO Year
  • WHD 2018
  • IOVA N/A
  • Fundamental
  • Price
  • WHD $40.26
  • IOVA $2.22
  • Analyst Decision
  • WHD Buy
  • IOVA Buy
  • Analyst Count
  • WHD 4
  • IOVA 11
  • Target Price
  • WHD $50.75
  • IOVA $11.90
  • AVG Volume (30 Days)
  • WHD 602.4K
  • IOVA 9.5M
  • Earning Date
  • WHD 10-29-2025
  • IOVA 11-06-2025
  • Dividend Yield
  • WHD 1.29%
  • IOVA N/A
  • EPS Growth
  • WHD N/A
  • IOVA N/A
  • EPS
  • WHD 2.67
  • IOVA N/A
  • Revenue
  • WHD $1,119,196,000.00
  • IOVA $241,525,000.00
  • Revenue This Year
  • WHD N/A
  • IOVA $67.40
  • Revenue Next Year
  • WHD $25.77
  • IOVA $56.32
  • P/E Ratio
  • WHD $15.06
  • IOVA N/A
  • Revenue Growth
  • WHD N/A
  • IOVA 636.99
  • 52 Week Low
  • WHD $33.80
  • IOVA $1.64
  • 52 Week High
  • WHD $70.01
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • WHD 45.41
  • IOVA 43.75
  • Support Level
  • WHD $39.69
  • IOVA $2.27
  • Resistance Level
  • WHD $42.00
  • IOVA $2.38
  • Average True Range (ATR)
  • WHD 1.46
  • IOVA 0.14
  • MACD
  • WHD -0.09
  • IOVA -0.01
  • Stochastic Oscillator
  • WHD 14.21
  • IOVA 28.21

About WHD Cactus Inc.

Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: